Fluenz Tetra live attenuated quadrivalent influenza vaccine— A Comprehensive Overview
What Is Fluenz Tetra? Fluenz Tetra is a live attenuated quadrivalent influenza vaccine, administered intranasally as a needle-free spray. It protects against four influenza…
Read more →EMA Confirms Suicidal Thoughts with Finasteride — Detailed summary, implications, and a practical pharmacovigilance / manufacturer action plan
Source documents: EMA PRAC communications and referral page (May–June 2025). European Medicines Agency (EMA)+1 Executive summary — the one-minute version What PRAC found (evidence…
Read more →EMA’s Update on Azithromycin Use — May 23, 2025
Key Regulatory Shift The European Medicines Agency’s (EMA) CHMP recommended updating the approved uses of azithromycin (oral and IV) to combat rising antimicrobial resistance…
Read more →Deep brief — Formal Meetings Between FDA and Sponsors/Applicants of BsUFA Products
Guidance for Industry (CDER & CBER, July 2025) — what it says, why it matters, and exactly what regulatory, pharmacovigilance (PV), quality, clinical and…
Read more →Deep Brief — Medical Device User Fee Small Business Qualification & Determination (FDA guidance, July 31, 2025)
What it is, why it matters, and exactly what manufacturers — including regulatory, PV/PS (pharmacovigilance / product safety), quality and finance teams — must…
Read more →Philips Respironics BiPAP A30 / A40 / V30 — Continuous Ventilator Correction, Clinical Risks, and Manufacturer Action Plan
Source: FDA Medical Device Recalls page (updated Aug 6, 2025).Link reviewed: FDA recall notice for Philips Respironics update of use instructions for BiPAP A30,…
Read more →